Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Task-State-Based Temporal Interference Stimulation (TI) to Improve Depression in Patients With Bipolar Disorder

NCT: NCT06516991 · COMPLETED

NCT IDNCT06516991
StatusCOMPLETED
Start Date2024-07-16
Completion2024-09-30

Brief Summary

The purpose of this study is to investigate the efficacy and safety of temporal interference stimulation (TI) in improving depressive episodes of bipolar disorder, to analyze the therapeutic principle of TI in bipolar disorder depressive episodes based on task state MRI scanning, and to explore the abnormal regulation mechanism of anhedonia neural circuit.

Frequently Asked Questions

What is Task-State-Based Temporal Interference Stimulation (TI) to Improve Depression in Patients With Bipolar Disorder?

Task-State-Based Temporal Interference Stimulation (TI) to Improve Depression in Patients With Bipolar Disorder is a clinical trial registered under NCT06516991. Current status: COMPLETED.

What is the status of NCT06516991?

The current status of NCT06516991 (Task-State-Based Temporal Interference Stimulation (TI) to Improve Depression in Patients With Bipolar Disorder) is: COMPLETED.

When did Task-State-Based Temporal Interference Stimulation (TI) to Improve Depression in Patients With Bipolar Disorder start?

Task-State-Based Temporal Interference Stimulation (TI) to Improve Depression in Patients With Bipolar Disorder started on 2024-07-16.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑